| （単位：十億ドル） | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | 0 | 0 | - | - | - | - | - |
| 研究開発費 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業費用 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | ||
| 純利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 純利益率（％） | - | - | - | - | - | - | - | - | ||
| 一株あたり利益 | - | - | - | - | - | - | -2.67 | -3.26 | -2.92 | -2.73 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -2.67 | -3.26 | -2.92 | -2.73 |
| EBITDA | - | - | - | - | - | -1 | - | - | - | - |